Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesUrothelial dysplasia and other flat lesions of the urinary bladder: clinicopathologic and molecular features
Human Pathology, 09/22/09
Hodges KB et al. – Recent molecular studies have provided further insight into the premalignant potential of these urothelial lesions. Herein, the authors present a review of flat urothelial lesions of the urinary bladder as defined by the 2004 World Health Organization classification with focus on the clinicopathologic, immunohistochemical, and molecular features.
Related Articles
Comparison of dysplasia profiles in stimulated ovaries and in those with a genetic risk for ovarian cancer
European Journal of Cancer, 10/20/09
Relevance Score: 46%
Heat-shock protein 70-2 (HSP70-2) expression in bladder urothelial carcinoma is associated with tumour progression and promotes migration and invasion
European Journal of Cancer, 11/19/09
Relevance Score: 45%
CD10 expression in urothelial carcinoma of the bladder
Diagnostic Pathology, 11/23/09
Relevance Score: 44%
Functional Transient Receptor Potential Vanilloid 1 is Expressed in Human Urothelial Cells
The Journal of Urology, 11/23/09
Relevance Score: 43%
Grading of gastric foveolar-type dysplasia in Barrett's esophagus
Modern Pathology, 10/23/09
Relevance Score: 43%
Today in Renal/Urologic...keeping you current
Receive free subspecialty "5-minute updates" via email
The development of risk groups in men with metastatic castration-resistant prostate cancer based on risk factors for PSA decline and survival
European Journal of Cancer, 12/16/09
Genetic variations in PI3K-AKT-mTOR pathway and bladder cancer risk
Carcinogenesis, 12/16/09
Leucinostatin A inhibits prostate cancer growth through reduction of insulin-like growth factor-I expression in prostate stromal cells
International Journal of Cancer, 12/16/09
Sponsor
Article Search
Sponsor
Sponsor